Unlock stock picks and a broker-level newsfeed that powers Wall Street.

ASX - Delayed Quote AUD

Proteomics International Laboratories Ltd (PIQ.AX)

Compare
0.4700
+0.0100
+(2.17%)
At close: 4:10:17 PM GMT+10
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
892.1430
892.1430
730.3400
1,489.3230
1,310.8240
Gross Profit
892.1430
892.1430
730.3400
1,489.3230
1,310.8240
Operating Expense
10,016.9180
10,016.9180
9,546.6360
8,407.4850
5,818.4170
Operating Income
-9,124.7750
-9,124.7750
-8,816.2960
-6,918.1620
-4,507.5930
Net Non Operating Interest Income Expense
259.0500
259.0500
136.5050
2.7450
8.0490
Other Income Expense
2,383.9120
2,383.9120
2,445.4810
1,942.4570
1,639.8810
Pretax Income
-6,481.8130
-6,481.8130
-6,234.3100
-4,972.9600
-2,859.6630
Net Income Common Stockholders
-6,376.2190
-6,376.2190
-6,234.3100
-4,972.9600
-2,859.6630
Basic EPS
-0.05
-0.05
-0.05
-0.05
-0.03
Diluted EPS
-0.05
-0.05
-0.05
-0.05
-0.03
Basic Average Shares
125,848.9280
125,848.9280
116,453.6920
105,531.2170
101,703.3610
Diluted Average Shares
125,848.9280
125,848.9280
116,453.6920
105,531.2170
101,703.3610
Net Income from Continuing & Discontinued Operation
-6,376.2190
-6,376.2190
-6,234.3100
-4,972.9600
-2,859.6630
Normalized Income
-6,391.4490
-6,391.4490
-6,246.1670
-4,972.9600
-2,859.6630
Interest Income
282.2270
282.2270
136.5050
5.4380
14.3860
Interest Expense
--
--
--
0.4460
0.1020
Net Interest Income
259.0500
259.0500
136.5050
2.7450
8.0490
EBIT
-9,124.7750
-9,124.7750
-8,816.2960
-4,972.5140
-2,859.5610
EBITDA
-8,397.0810
-8,397.0810
-8,286.7670
-4,555.6530
-2,487.0430
Reconciled Depreciation
727.6940
727.6940
529.5290
416.8610
372.5180
Net Income from Continuing Operation Net Minority Interest
-6,376.2190
-6,376.2190
-6,234.3100
-4,972.9600
-2,859.6630
Total Unusual Items Excluding Goodwill
15.2300
15.2300
11.8570
--
--
Total Unusual Items
15.2300
15.2300
11.8570
--
--
Normalized EBITDA
-8,412.3110
-8,412.3110
-8,298.6240
-4,555.6530
-2,487.0430
6/30/2021 - 4/16/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BTC.AX BTC Health Limited
0.0500
0.00%
 
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
 
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0350
0.00%
 
RNV.AX RENERVE FPO [RNV]
0.1100
-4.35%
 
TRP.AX Tissue Repair Ltd
0.2350
-4.08%
 
ANR.AX Anatara Lifesciences Ltd
0.0060
0.00%
 
VBS.AX Vectus Biosystems Limited
0.0800
0.00%
 
CMB.AX Cambium Bio Limited
0.2800
0.00%
 
BGT.AX Bio-Gene Technology Limited
0.0310
0.00%
 
ATX.AX Amplia Therapeutics Limited
0.0520
-7.14%